Cholesterol Drug Cost Comparison Calculator
See how much you'd pay monthly and annually for statins versus PCSK9 inhibitors based on your insurance coverage.
Monthly Cost: Statins
Based on your insurance type
Monthly Cost: PCSK9 Inhibitors
If covered by insurance
Annual Cost Difference
Note: PCSK9 inhibitors require documented statin intolerance or LDL >70 mg/dL despite maximum statin therapy.
Many patients qualify for patient assistance programs to reduce costs significantly.
When it comes to lowering bad cholesterol, two main types of drugs dominate: statins and PCSK9 inhibitors. Both work to reduce LDL - the kind that clogs arteries - but they’re nothing alike in how they work, how they feel to take, and what they cost. If you’ve been told you need to lower your cholesterol and are weighing your options, here’s what actually matters.
How They Work - Completely Different Paths
Statins have been around since the late 1980s. They block an enzyme in your liver called HMG-CoA reductase, which is needed to make cholesterol. Less production means your liver pulls more LDL out of your blood to use as building material. It’s like turning down the faucet while also sucking more water out of the tub.
PCSK9 inhibitors work differently. They’re injectable drugs - alirocumab and evolocumab are the two main ones. They stop a protein called PCSK9 from destroying LDL receptors on your liver cells. More receptors mean your liver can grab and remove way more LDL from your bloodstream. Think of it like adding more bouncers to a club so more people (LDL) get kicked out.
The result? Statins typically lower LDL by 30% to 50%. High-intensity statins like rosuvastatin or atorvastatin push toward the top end. PCSK9 inhibitors? They drop LDL by 50% to 61% - often more than doubling the effect of even the strongest statins. Combine them, and you can see reductions up to 75%.
Side Effects: Muscle Pain vs. Injection Anxiety
Statins are the most prescribed cholesterol drug in history - about 40 million Americans take them. But they come with a well-known downside: muscle pain. About 5% to 10% of people experience it, and for some, it’s bad enough to quit. It’s not just soreness - it’s deep, persistent ache that doesn’t go away with rest. Some report brain fog, too, though studies on that are mixed.
PCSK9 inhibitors don’t cause muscle pain. In fact, many patients switch to them after years of statin intolerance. A Reddit thread from someone who switched from atorvastatin to evolocumab after 10 years of muscle pain had over 140 upvotes. The feedback? “Life-changing.”
But PCSK9 inhibitors have their own issues. You have to inject them - either every two weeks or once a month. That’s a hurdle for people who hate needles. About 41% of users on Drugs.com mention injection anxiety. Some get redness or swelling at the injection site. It’s usually mild, but it’s enough for a small number to stop.
Here’s another key difference: statins slightly raise the risk of hemorrhagic stroke in certain people - by about 22%, according to UCLA research. PCSK9 inhibitors? No increase in hemorrhagic stroke risk found across 36 trials. That matters if you have high blood pressure or a history of brain bleeds.
Outcomes: Who Lives Longer?
It’s not just about lowering numbers. What matters is whether you have fewer heart attacks, strokes, or deaths.
Statins have decades of proof. They reduce heart attack risk by 25% to 35% in high-risk people. That’s why they’re still the first choice for nearly everyone.
PCSK9 inhibitors don’t just lower LDL - they save lives too. The FOURIER trial showed evolocumab reduced heart attacks by 15% and strokes by 20% over two years in people already on statins. The ODYSSEY trial showed similar results with alirocumab. When added to statins, they cut major cardiovascular events by 27% in high-risk patients.
But here’s the catch: PCSK9 inhibitors are almost always used on top of statins. Very few people take them alone. So we don’t have long-term data on them as a standalone treatment. Statins, on the other hand, have been proven to cut death rates by up to 30% in people with heart disease.
Cost: a Month vs. ,000 a Year
This is where things get ugly.
Generic statins? You can get them for $4 to $10 a month. Even brand-name versions rarely go over $50. They’re cheap, widely available, and covered by every insurance plan.
PCSK9 inhibitors? Around $5,000 to $14,000 a year. That’s not a typo. Even with discounts and coupons, many patients still pay $300 a month out of pocket.
Insurance won’t cover them unless you’ve tried and failed on statins - or can’t tolerate them. In fact, 87% of U.S. insurers require documented statin intolerance or LDL levels above 70 mg/dL despite maximum statin therapy before approving PCSK9 inhibitors. That means you might need to try two or three different statins, get blood tests, and have your doctor write a letter before you even get a prescription.
Some manufacturers offer support programs - Amgen’s Repatha SupportPlus and Sanofi’s Praluent Support help with insurance paperwork and even provide free injections for those who qualify. But it’s still a battle.
Who Gets Which Drug?
Statins are for almost everyone. If you have high cholesterol, diabetes, high blood pressure, or a family history of early heart disease - start with a statin. It’s the gold standard for a reason.
PCSK9 inhibitors are for the few who need more. That includes:
- People with familial hypercholesterolemia - inherited high cholesterol that doesn’t respond well to statins alone
- Those with existing heart disease or stroke who still have LDL above 70 mg/dL on maximum statin therapy
- Patients who develop muscle pain, liver issues, or other side effects from statins
- People with very high risk - like those with diabetes plus kidney disease or multiple heart attacks
A real case from the FH Foundation: a 42-year-old with familial hypercholesterolemia had LDL of 286 mg/dL on high-dose rosuvastatin. After adding alirocumab, it dropped to 58 mg/dL. That’s the kind of result PCSK9 inhibitors can deliver when statins aren’t enough.
What’s Coming Next?
PCSK9 inhibitors aren’t the end of the road. In 2021, the FDA approved inclisiran (Leqvio), a twice-yearly injection that silences the PCSK9 gene. It’s easier than monthly shots - just two needles a year. Early data shows LDL reductions of 50% or more.
Even more exciting? Oral PCSK9 inhibitors are in Phase II trials. Merck’s MK-0616 lowered LDL by 60% in early studies. If approved, it could be the game-changer - the same power as injections, without needles.
For now, though, your choices are clear: statins for most, PCSK9 inhibitors for those who need more.
What About Other Options?
You might hear about ezetimibe (Zetia) or bempedoic acid (Nexletol). Ezetimibe lowers LDL by 15% to 20% and is often added to statins. It’s cheap and well-tolerated. Bempedoic acid is another option for statin-intolerant patients - it works in the liver like statins but doesn’t enter muscle tissue, so muscle pain is rare. But neither comes close to the LDL-lowering power of PCSK9 inhibitors.
And then there’s the elephant in the room: lifestyle. Diet, exercise, and weight loss still matter. No drug replaces a healthy lifestyle. But when genetics or disease push your numbers too high, medication becomes essential.
Final Thoughts: It’s Not Either/Or - It’s Step-by-Step
Statins are the foundation. PCSK9 inhibitors are the upgrade. You don’t choose one over the other - you choose when to add the upgrade.
If your LDL is still above 70 mg/dL after trying a statin, talk to your doctor. If you can’t take statins at all because of side effects, PCSK9 inhibitors might be your best shot. And if cost is a barrier, ask about patient assistance programs. Many people get them for free or at deep discounts.
The goal isn’t just to lower a number. It’s to live longer, avoid heart attacks, and keep moving. For most, statins do that. For some, PCSK9 inhibitors make the difference between barely holding on and truly thriving.
Can PCSK9 inhibitors replace statins completely?
PCSK9 inhibitors can be used alone in rare cases, like severe statin intolerance, but they’re almost always added to statins. Statins have proven benefits beyond cholesterol lowering - like reducing inflammation and stabilizing artery plaques - that PCSK9 inhibitors don’t fully replicate. So unless you can’t take statins at all, doctors will usually keep you on both.
Do PCSK9 inhibitors cause weight gain or diabetes?
No. Unlike some older cholesterol drugs, PCSK9 inhibitors haven’t been linked to weight gain, increased blood sugar, or new-onset diabetes. Statins, on the other hand, carry a small increased risk of diabetes - about 9% to 12% over several years - especially in people already at risk. That’s another reason PCSK9 inhibitors may be preferred for prediabetic patients.
How long do you need to take PCSK9 inhibitors?
You take them for life - just like statins. Cholesterol doesn’t go away just because you take a shot. Stopping means LDL levels bounce back within weeks. Long-term data shows they’re safe for at least five years, and studies are ongoing to track 10-year outcomes. There’s no evidence of long-term harm.
Are PCSK9 inhibitors safe for older adults?
Yes. Clinical trials included patients over 75, and no increased safety risks were found. In fact, older adults with heart disease often benefit the most because they’re at highest risk. The main concerns are injection technique and cost - not age-related side effects. Many seniors manage injections well with help from nurses or family.
Can I switch from statins to PCSK9 inhibitors on my own?
No. Never stop or switch cholesterol meds without talking to your doctor. Statins protect against heart attacks even if your LDL seems “normal.” Abruptly stopping can raise your risk. PCSK9 inhibitors require insurance approval and medical supervision. Your doctor will check your LDL, kidney function, and overall risk before making a change.
Dec 8, 2025 — Michael Robinson says :
So basically, statins are the cheap, tried-and-true hammer, and PCSK9 inhibitors are the fancy laser tool you only bring out when the hammer won’t cut it. Makes sense. Life’s like that a lot - simple solutions first, expensive upgrades if you still can’t fix the problem.